Search results
Found 286 matches for
While research has already established that B vitamin supplements can help slow mental decline in older people with memory problems, an international team have now found that having higher levels of Omega-3 fatty acids in your body could boost the B vitamins' effect.
NDCN researchers to co-lead new £50m MRC Centre to develop medical device-based therapies for brain conditions
27 June 2025
A new Medical Research Council Centre of Research Excellence (MRC CoRE) aims to develop brain stimulation devices to treat conditions such as Parkinson’s, dementia, stroke and childhood epilepsy.
Alan Davidson Foundation renews funding for ground-breaking motor neuron disease research at Oxford
20 June 2025
As part of its renewed commitment, the Alan Davidson Foundation will continue to fund a full-time project manager to facilitate the ongoing coordination and growth of the ACORN study. The foundation is also contributing to the cost of a research fellow to support the next phase of the project.
New OPM-MEG brain scanner installed at the Oxford Centre for Human Brain Activity (OHBA)
19 June 2025
The advanced technology will open new avenues for research, including scanning children, dementia patients and enable full-body movement studies.
First author publication for final year medical student on Parkinson’s Disease review
13 June 2025
Patrick Oliver, a final year medical student at Oxford, has worked with Oxford Parkinson’s Disease Centre to get a first author publication on a new review of the gut brain axis in Parkinson’s disease.
Study highlights effectiveness of neuromodulatory therapy on severe epileptic focal seizures
6 June 2025
A long-term clinical study has confirmed the effectiveness of a neuromodulatory treatment for severe focal seizures in both children and adults with drug-resistant epilepsy (DRE) and demonstrated the therapy’s lasting impact.
New paper explores how the immune system fails in CASPR2-antibody encephalitis
22 May 2025
The findings shed new light on how the body’s own defenses can mistakenly turn against the brain - and potentially opens the door to more targeted treatments.
First participant recruited to pioneering UK trial in global effort to tackle early causes of Parkinson’s
8 May 2025
A pioneering clinical trial for people with a sleep disorder who are at higher risk of developing Parkinson’s has recruited its first UK participant from the Discovery Cohort study at the Oxford Parkinson’s Disease Centre (OPDC)
Oxford-led cross-divisional collaboration wins the prestigious Cozzarelli Prize
30 April 2025
A collaborative study between the Medical Sciences Division and the Mathematical, Physical and Life Sciences Division at the University of Oxford has been awarded the 2024 PNAS Cozzarelli Prize in Biomedical Science.
Sleep, dance and rhythms of life
29 April 2025
To mark International Dance Day on 29 April, Akanksha Bafna talks about her latest paper and shares how she combines her research into sleep and circadian rhythms with her personal passion for music and dance to help her understand the importance of rhythm in our daily lives.
Research about whiplash published in two new papers
19 March 2025
The findings come from the Neuromusculoskeletal Health and Science Lab’s whiplash cohort.
Anticholinergic medications given to people with psychosis could worsen memory
26 February 2025
Medications routinely given to people experiencing psychosis could be worsening some of their cognitive function, including memory and concentration, according to a new analysis of existing research.
Novel AI tool studies cellular interactions in human brain tissues
20 February 2025
Dr David A Menassa is one of the senior authors on a new paper in Nature Communications that reports on the use of DeepCellMap - an adaptable open-source deep learning tool which studies cellular interactions in human brain tissues in an automated way.
New study reveals genetic effects on cognitive health are age and sex specific
5 February 2025
A recent study from a team at University of Oxford aimed to reveal the specific roles played by APOE and Klotho genes in brain health and function, and how this varies according to age and sex.
New research to use focused ultrasound technology to address cognitive decline in Lewy body dementia patients
22 January 2025
A collaboration between The Focused Ultrasound Foundation and Race Against Dementia to fund the innovative clinical trial.
NDCN researchers awarded ARIA funding for future adoption of neurotechnologies
21 January 2025
Project teams led by Associate Professor Melanie Fleming and Professor Ben Seymour have been awarded funding from the Advanced Research + Invention Agency (ARIA) to advance research that could unlock next-generation precision neurotechnologies.
Oxford and partners lead on two new MRC Centres to create cutting-edge gene therapies
11 December 2024
Oxford University researchers are to lead and co-lead on two MRC research centres, which are being launched to develop new advanced treatments for currently untreatable diseases.
Wearable devices can help predict falls in Parkinson’s Disease over five years
5 December 2024
A new study from the NeuroMetrology lab demonstrates how clinicians could make data-backed predictions of falls in people with Parkinson’s Disease (PD) to help improve effective longer term care planning.
Leading academics recognised on Clarivate Highly Cited List
20 November 2024
Six researchers from the Nuffield Department of Clinical Neuroscience have made it onto the 2024 list.
Study finds important link between genetic markers and neuropathic pain
31 October 2024
European researchers have mapped the most comprehensive phenotyping of neuropathic pain and identified genetic markers associated with this serious condition. The new findings could be especially important for diabetes patients.